GoodRx Holdings (GDRX) Stock Forecast & Price Target

Compare

1,194 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GDRX Analyst Ratings

Moderate Buy

7 Buy

4 Hold

1 Sell

Based on 12 analysts giving stock ratings to

GoodRx

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GDRX Stock 12 Month Forecast

Average Price Target

$6.34

▲(28.60%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for GoodRx Holdings in the last 3 months. The average price target is $6.34 with a high forecast of $9.00 and a low forecast of $4.00. The average price target represents a 28.60% change from the last price of $4.93.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","4":"$4","6":"$6","8":"$8","10":"$10"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$9.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4,6,8,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.82,4.218461538461538,4.616923076923077,5.015384615384615,5.413846153846153,5.812307692307692,6.21076923076923,6.609230769230768,7.007692307692308,7.406153846153845,7.804615384615384,8.203076923076923,8.60153846153846,{"y":9,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.82,4.013846153846154,4.207692307692308,4.401538461538461,4.595384615384615,4.789230769230769,4.983076923076923,5.176923076923076,5.3707692307692305,5.564615384615385,5.758461538461538,5.952307692307691,6.146153846153846,{"y":6.34,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.82,3.833846153846154,3.8476923076923075,3.8615384615384616,3.875384615384615,3.8892307692307693,3.903076923076923,3.916923076923077,3.9307692307692306,3.9446153846153846,3.9584615384615383,3.9723076923076923,3.9861538461538464,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.87,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.82,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.9,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.93,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.19,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.95,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.64,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$9.00

Average Price Target$6.34

Lowest Price Target$4.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$5.5

Hold

11.56%

Upside

Reiterated

06/25/25

GoodRx Holdings demonstrates strong financial performance and positive technical indicators, but faces challenges with high valuation and external uncertainties, such as the Rite Aid bankruptcy. The company's strategic direction and leadership changes provide potential upside, but investors should be cautious of the current high valuation.

John RansomRaymond James

Raymond James

$4.5→$9

Buy

82.56%

Upside

Reiterated

06/13/25

Raymond James Sticks to Its Buy Rating for GoodRx Holdings (GDRX)

Stan BerenshteynWells Fargo

Wells Fargo

Buy

41.99%

Upside

Reiterated

06/13/25

GoodRx Holdings: Strategic Market Expansion and Growth Potential Drive Buy Rating

Glen SantangeloJefferies

Jefferies

$6→$5.5

Buy

11.56%

Upside

Reiterated

06/12/25

Jefferies Keeps Their Buy Rating on GoodRx Holdings (GDRX)

Allen LutzBank of America Securities

Bank of America Securities

Sell

-18.86%

Downside

Reiterated

06/10/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (NASDAQ: GDRX) and Insmed (NASDAQ: INSM)

Michael ChernyLeerink Partners

Leerink Partners

Buy

41.99%

Upside

Reiterated

06/10/25

Strategic Expansion and Growth Potential: GoodRx Holdings' Innovative Subscription Service

Daniel GrosslightCiti

Citi

Buy

41.99%

Upside

Reiterated

06/10/25

GoodRx Holdings: Strategic Expansion and Competitive Pricing Drive Buy Rating with 70.3% Expected Return

Scott SchoenhausKeyBanc

KeyBanc

Buy

21.70%

Upside

Reiterated

05/14/25

KeyBanc Remains a Buy on GoodRx Holdings (GDRX)

Kevin CaliendoUBS

UBS

$6→$5.25

Hold

6.49%

Upside

Reiterated

05/13/25

GoodRx price target lowered to $5.25 from $6 at UBSGoodRx price target lowered to $5.25 from $6 at UBS

Jailendra SinghTruist Financial

Truist Financial

―

Hold

―

Reiterated

05/12/25

Truist Financial Sticks to Their Hold Rating for GoodRx Holdings (GDRX)

Eric SheridanGoldman Sachs

Goldman Sachs

$6→$5

Hold

1.42%

Upside

Reiterated

05/09/25

Expedia (EXPE) PT Lowered to $5 at Goldman SachsGoldman Sachs analyst Eric Sheridan lowered the price target on Expedia (NASDAQ: EXPE) to $5.00 (from $6.00) while maintaining a Neutral rating.

Craig HettenbachMorgan Stanley

Morgan Stanley

Hold

21.70%

Upside

Reiterated

05/08/25

Hold Rating for GoodRx Holdings Amid Revenue Challenges and Uncertainties

Charles RhyeeTD Cowen

TD Cowen

Buy

62.27%

Upside

Reiterated

05/08/25

TD Cowen Sticks to Its Buy Rating for GoodRx Holdings (GDRX)

Steven ValiquetteMizuho Securities

Mizuho Securities

Hold

1.42%

Upside

Reiterated

03/03/25

Balanced Outlook on GoodRx Holdings: Growth Potential Amidst Cautious Market Expectations

Sean DodgeRBC Capital

RBC Capital

Buy

21.70%

Upside

Reiterated

02/27/25

GoodRx Holdings (GDRX) Gets a Buy from RBC Capital

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$5.5

Hold

11.56%

Upside

Reiterated

06/25/25

John RansomRaymond James

Raymond James

$4.5→$9

Buy

82.56%

Upside

Reiterated

06/13/25

Raymond James Sticks to Its Buy Rating for GoodRx Holdings (GDRX)

Stan BerenshteynWells Fargo

Wells Fargo

Buy

41.99%

Upside

Reiterated

06/13/25

GoodRx Holdings: Strategic Market Expansion and Growth Potential Drive Buy Rating

Glen SantangeloJefferies

Jefferies

$6→$5.5

Buy

11.56%

Upside

Reiterated

06/12/25

Jefferies Keeps Their Buy Rating on GoodRx Holdings (GDRX)

Allen LutzBank of America Securities

Bank of America Securities

Sell

-18.86%

Downside

Reiterated

06/10/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (NASDAQ: GDRX) and Insmed (NASDAQ: INSM)

Michael ChernyLeerink Partners

Leerink Partners

Buy

41.99%

Upside

Reiterated

06/10/25

Strategic Expansion and Growth Potential: GoodRx Holdings' Innovative Subscription Service

Daniel GrosslightCiti

Citi

Buy

41.99%

Upside

Reiterated

06/10/25

GoodRx Holdings: Strategic Expansion and Competitive Pricing Drive Buy Rating with 70.3% Expected Return

Scott SchoenhausKeyBanc

KeyBanc

Buy

21.70%

Upside

Reiterated

05/14/25

KeyBanc Remains a Buy on GoodRx Holdings (GDRX)

Kevin CaliendoUBS

UBS

$6→$5.25

Hold

6.49%

Upside

Reiterated

05/13/25

GoodRx price target lowered to $5.25 from $6 at UBSGoodRx price target lowered to $5.25 from $6 at UBS

Jailendra SinghTruist Financial

Truist Financial

―

Hold

―

Reiterated

05/12/25

Truist Financial Sticks to Their Hold Rating for GoodRx Holdings (GDRX)

Eric SheridanGoldman Sachs

Goldman Sachs

$6→$5

Hold

1.42%

Upside

Reiterated

05/09/25

Expedia (EXPE) PT Lowered to $5 at Goldman SachsGoldman Sachs analyst Eric Sheridan lowered the price target on Expedia (NASDAQ: EXPE) to $5.00 (from $6.00) while maintaining a Neutral rating.

Craig HettenbachMorgan Stanley

Morgan Stanley

Hold

21.70%

Upside

Reiterated

05/08/25

Hold Rating for GoodRx Holdings Amid Revenue Challenges and Uncertainties

Charles RhyeeTD Cowen

TD Cowen

Buy

62.27%

Upside

Reiterated

05/08/25

TD Cowen Sticks to Its Buy Rating for GoodRx Holdings (GDRX)

Steven ValiquetteMizuho Securities

Mizuho Securities

Hold

1.42%

Upside

Reiterated

03/03/25

Balanced Outlook on GoodRx Holdings: Growth Potential Amidst Cautious Market Expectations

Sean DodgeRBC Capital

RBC Capital

Buy

21.70%

Upside

Reiterated

02/27/25

GoodRx Holdings (GDRX) Gets a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GoodRx Holdings

1 Month

xxx

Success Rate

10/19 ratings generated profit

Average Return

+1.89%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 52.63% of your transactions generating a profit, with an average return of +1.89% per trade.

3 Months

xxx

Success Rate

11/19 ratings generated profit

Average Return

+5.18%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 57.89% of your transactions generating a profit, with an average return of +5.18% per trade.

1 Year

Michael ChernyLeerink Partners

Success Rate

11/16 ratings generated profit

Average Return

+4.04%

reiterated a buy rating 19 days ago

Copying Michael Cherny's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +4.04% per trade.

2 Years

xxx

Success Rate

7/14 ratings generated profit

Average Return

+2.95%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +2.95% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GDRX Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GDRX has received 14 Buy Ratings, 6 Hold Ratings, and 3 Sell Ratings. GDRX average Analyst price target in the past 3 months is 6.34.

Each month's total comprises the sum of three months' worth of ratings.

GDRX Financial Forecast

GDRX Earnings Forecast

Next quarter’s earnings estimate for GDRX is $0.10 with a range of $0.09 to $0.12. The previous quarter’s EPS was $0.09. GDRX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year GDRX has Preformed in-line its overall industry.

GDRX Sales Forecast

Next quarter’s sales forecast for GDRX is $205.87M with a range of $204.70M to $208.12M. The previous quarter’s sales results were $202.97M. GDRX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 57.81% of the time in the same period. In the last calendar year GDRX has Outperformed its overall industry.

GDRX Stock Forecast FAQ

What is GDRX’s average 12-month price target, according to analysts?

Based on analyst ratings, Goodrx Holdings, Inc.’s 12-month average price target is 6.34.

What is GDRX’s upside potential, based on the analysts’ average price target?

Goodrx Holdings, Inc. has 28.60% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GDRX a Buy, Sell or Hold?

Goodrx Holdings, Inc. has a consensus rating of Moderate Buy which is based on 7 buy ratings, 4 hold ratings and 1 sell ratings.

What is Goodrx Holdings, Inc.’s price target?

The average price target for Goodrx Holdings, Inc. is 6.34. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $4.00. The average price target represents 28.60% Increase from the current price of $4.93.

What do analysts say about Goodrx Holdings, Inc.?

Goodrx Holdings, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of GDRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

GoodRx Holdings (GDRX) Stock Forecast & Price Target

GDRX Analyst Ratings

GDRX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GoodRx Holdings

GDRX Analyst Recommendation Trends

GDRX Financial Forecast

GDRX Earnings Forecast

GDRX Sales Forecast

GDRX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts